This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Menquadfi, Nimenrix, Penbraya
- Generic Name
- Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen
- DrugBank Accession Number
- DB15681
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Conjugate - Synonyms
- Nimenrix component neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen
Pharmacology
- Indication
This antigen is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. It is approved for use in individuals 10 through 25 years of age.1
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Invasive meningococcal disease caused by neisseria meningitidis serogroup c •••••••••••• ••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ZT89E5A103
- CAS number
- Not Available
References
- General References
- DailyMed Label: PENBRAYA (Meningococcal Groups A, B, C, W, and Y Vaccine), suspension for intramuscular injection [Link]
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Recruiting Prevention Healthy Volunteers (HV) / Meningococcal Infections 1 3 Active Not Recruiting Prevention Meningococcal Immunisation (Healthy Volunteers) 1 3 Active Not Recruiting Prevention Meningococcal Infection (Healthy Volunteers) 1 3 Completed Prevention Meningococcal Infection (Healthy Volunteers) 2 3 Completed Prevention Meningococcal Infections 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intramuscular Solution Intramuscular Injection, suspension Intramuscular 10 mcg Injection, powder, for solution Intramuscular Solution Subcutaneous Injection, powder, lyophilized, for suspension; kit; suspension Intramuscular - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at May 01, 2020 13:01 / Updated at April 08, 2024 21:18